Revivia BioPharm can align your company's manufacturing systems and processes with your business goals. We provide everything from integrated manufacturing and economic modeling and support solutions, to market reporting services and potential clients. So no matter what level of service or support your business requires, we can engage in a way that's just right for you.
|
Today at Reviva BioPharm, we're helping customers around the globe, especially in mainland China develop and maintain the edge required for success in a competitive business environment. As a pioneer in biomanufacturing solutions for China area, we're turning domestic developing organizations into solid, bottom-line contributors to the total international enterprise. Cutting costs and increasing speed-to-market, while improving agility and enhancing total operational efficiencies along the way.
|
What we can do:
- We can help you consistently meet engineering and project objectives on time, and on budget.
- Bridge the gaps between technology developments and process solutions, finally to the true market.
- Our manufacturing expertise enables you to satisfy your customers. And beat your competition.
|
Why you should choose us:
- Breadth of knowledge - We offer implementation services and support for a full range of Raw Drug Materials and Active Pharmaceutical Ingredients (APIs), from DMP preparation to help you find the true client.
- Deep industry expertise - Our staff has over 60 combined years of experience in Biomedicine and pharmaceutical industry field, and unparalleled expertise with formulation and cGMP of brand and Generic drugs in this area.
- High quality - Our clients are consistently satisfied with our work, and return year after year for additional support and solutions for their increasing needs.
- Flexibility - We are a highly responsive and non-bureaucratic organization. We get the work done in an expedient and efficient manner.
- Value - Our services are priced to fit your budget constraints and provide excellent return for your investment in Biomedicine and pharmaceutical filed.
|
|